Evaluation of Lovastatin in Severe Persistent Asthma

NCT00689806 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study never opened

Conditions

Severe Persistent Asthma

Interventions

DRUG: Lovastatin
DRUG: Placebo

Sponsor

University of Chicago